Alzheimer Society of Canada
14
4
4
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
7%
1 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
The Brain Health PRO Online Risk Factor Reduction Study to Prevent Dementia
Role: collaborator
Comprehensive Assessment of Neurodegeneration and Dementia
Role: collaborator
Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia
Role: collaborator
Creatine and Resistance Training in Older Adults With Mild Cognitive Impairment
Role: collaborator
Deep Brain Stimulation of the Pedunculopontine Nucleus for Alzheimer's Disease
Role: collaborator
Collaborative Power Mobility Innovative Learning OpporTunity (CoPILOT) - A Pilot Study of a New Training Approach (Phase 1)
Role: collaborator
Collaborative Power Mobility Innovative Learning OpporTunity (CoPILOT) - A Pilot Study of a New Training Approach (Phase 2)
Role: collaborator
Sleep Apnea and Cognition in Older Adults
Role: collaborator
Dementia Moves: Protocol for a Feasibility Study
Role: collaborator
Evaluation of a New CBT for People With Alzheimer's Disease and Their Caregivers
Role: collaborator
Deprescribing Intervention Among Nursing Home Residents With Major Neurocognitive Disorders
Role: collaborator
Serotonergic Function and Behavioural and Psychological Symptoms of Frontotemporal Dementia
Role: collaborator
Supporting Caregivers of Persons With Dementia: A Pilot Study
Role: collaborator
Mindfulness Research Program: Designed to Enhance Wellbeing in People Living With Dementia and Their Spouses
Role: collaborator
All 14 trials loaded